Neonatal short bowel syndrome

J Pediatr. 1991 Jul;119(1 Pt 1):18-23. doi: 10.1016/s0022-3476(05)81032-7.

Abstract

In this retrospective study the management of infants who had undergone resection of more than 50% of the small bowel as newborn infants between 1970 and 1988 was analyzed to define prognostic factors. Small bowel resections were performed for atresia (36 cases), volvulus (22 cases), gastroschisis (10 cases), necrotizing enterocolitis (11 cases), and other disorders (8 cases). Patients were classified into two groups depending on the length of residual small bowel: group 1 (n = 35) had less than 40 cm of small bowel and group 2 (n = 51) had 40 to 80 cm of residual small bowel. Patients in group 2 had significantly better survival rates than those in group 1 (92.0% vs 66.6%; p less than 0.001). The patients in group 1 who were born after 1980, when home parenteral nutrition was introduced, had better survival rates than those who were treated before 1980 (95.0% vs 65.0%; p less than 0.01). The time required for acquisition of intestinal adaptation depended on the intestinal length (average, 27.3 months for group 1 and 14 months for group 2; p less than 0.01) and on the presence or absence of the ileocecal valve. Parenteral or supportive enteral nutrition, or both, ensured normal growth in both groups. We conclude that more than 90% of infants now survive after extensive small bowel resection with parenteral nutrition and that the remaining small intestine will adapt with time. Home-based parenteral nutrition allowed children to be treated in the best psychosocial environment.

MeSH terms

  • Adaptation, Physiological
  • Enteral Nutrition
  • Female
  • Follow-Up Studies
  • Humans
  • Ileocecal Valve
  • Infant, Newborn
  • Intestinal Atresia / surgery
  • Intestinal Diseases / surgery
  • Male
  • Parenteral Nutrition
  • Parenteral Nutrition, Home
  • Prognosis
  • Retrospective Studies
  • Short Bowel Syndrome / mortality*
  • Short Bowel Syndrome / physiopathology
  • Short Bowel Syndrome / therapy
  • Survival Rate
  • Time Factors